ERD

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

01-01-2017

-

30-06-2023

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

CarrerasPathfinders | Enabling the next generation in search of blood cancer cures

01-09-2024

-

31-08-2029

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

CarrerasLeaders | Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

01-01-2023

-

31-12-2027

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

HARMONY PLUS | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

01-10-2020

-

31-03-2024

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Maxima Butterfly | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

01-01-2023

-

31-12-2027

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

NUCLEAR | METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY

01-03-2025

-

28-02-2029

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

IRB-TARGET | IRB Barcelona International PhD programme: on TARGET for high-impact biomedicine

01-09-2024

-

31-08-2029

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

SECURED | Scaling Up secure Processing, Anonymization and generation of Health Data for EU cross border collaborative research and Innovation

01-01-2023

-

31-12-2025

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

IMMERGE | Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches

01-01-2024

-

31-12-2027

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Adaptmet | Deconstructing adaptive evolution of metastasis

01-03-2025

-

28-02-2029

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

CLOSER | Childhood Leukemia: Overcoming distance between South America and Europe Regions

01-01-2019

-

31-03-2024

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

THRIVE | TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS

01-12-2023

-

30-11-2028

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

RELEVANCE | Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance

01-09-2015

-

30-11-2019

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics

01-05-2020

-

31-10-2025

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

ChroMe | Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living

01-03-2016

-

29-02-2020

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Evomet | Deconstructing the evolution of metastasis

01-03-2021

-

28-02-2025

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

INTERCEPT-MDS | Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells.

01-01-2021

-

31-12-2024

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

PIPgen | PI3K/PTEN-related monogenic disease to understand cancer

01-07-2021

-

30-06-2025

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

CANCERNA | RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY

01-06-2022

-

31-05-2025

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

CARxALL | Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia

01-04-2023

-

31-03-2026

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

FUN-HSC | TACKLING FUNCTIONAL MATURATION FOR TRANSPLANTABLE HEMATOPOIETIC STEM CELL GENERATION

01-01-2024

-

31-12-2028

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

ALERT | Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia

01-09-2023

-

28-02-2026

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

CARLY | Development and characterization of a novel CAR T-cell therapy for NHL

01-01-2025

-

30-06-2027

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

SIRT7-LC | Role of the SIRT7-NPM-c-Myc pathway in lung cancer

01-09-2023

-

31-08-2025

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

StemLinc | Identification and characterization of long non-coding RNAs as drivers of stemness in hematopoietic stem cells and leukemia.

01-01-2023

-

31-12-2024

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

ChroMet | Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate.

01-08-2024

-

31-07-2026

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

BiTE-CAR | CD22/CD19 dual redirection Dual targeting of CD22 and CD19 with BiTE-secreting and CAR-expressing bispecific T-cells for adoptive Cellular ImmunoTherapy in advanced B-cell Acute Lymphoblastic Leukemia

01-07-2023

-

31-12-2024

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia

01-01-2019

-

30-06-2020

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

INFANTLEUKEMIA | GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OF INFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA

01-01-2016

-

30-06-2021

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

IT4-TALL | Clinical translation of a novel CD1a-directed CAR for relapse/refractory cortical T-cell Acute Lymphoblastic Leukemia: feasibility, efficacy and safety

01-01-2021

-

30-06-2022

Show more information

Organisation FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Projects overview

Selected filters:

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

CarrerasPathfinders | Enabling the next generation in search of blood cancer cures

CarrerasLeaders | Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

HARMONY PLUS | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

Maxima Butterfly | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

NUCLEAR | METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY

IRB-TARGET | IRB Barcelona International PhD programme: on TARGET for high-impact biomedicine

SECURED | Scaling Up secure Processing, Anonymization and generation of Health Data for EU cross border collaborative research and Innovation

IMMERGE | Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches

Adaptmet | Deconstructing adaptive evolution of metastasis

CLOSER | Childhood Leukemia: Overcoming distance between South America and Europe Regions

THRIVE | TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS

RELEVANCE | Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance

cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics

ChroMe | Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living

Evomet | Deconstructing the evolution of metastasis

INTERCEPT-MDS | Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells.

PIPgen | PI3K/PTEN-related monogenic disease to understand cancer

CANCERNA | RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY

CARxALL | Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia

FUN-HSC | TACKLING FUNCTIONAL MATURATION FOR TRANSPLANTABLE HEMATOPOIETIC STEM CELL GENERATION

ALERT | Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia

CARLY | Development and characterization of a novel CAR T-cell therapy for NHL

SIRT7-LC | Role of the SIRT7-NPM-c-Myc pathway in lung cancer

StemLinc | Identification and characterization of long non-coding RNAs as drivers of stemness in hematopoietic stem cells and leukemia.

ChroMet | Elucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate.

BiTE-CAR | CD22/CD19 dual redirection Dual targeting of CD22 and CD19 with BiTE-secreting and CAR-expressing bispecific T-cells for adoptive Cellular ImmunoTherapy in advanced B-cell Acute Lymphoblastic Leukemia

IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia

INFANTLEUKEMIA | GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OF INFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA

IT4-TALL | Clinical translation of a novel CD1a-directed CAR for relapse/refractory cortical T-cell Acute Lymphoblastic Leukemia: feasibility, efficacy and safety